发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| USA | 51 |
| GERMANY (FED REP GER) | 14 |
| England | 12 |
| France | 10 |
| Spain | 10 |
| Italy | 8 |
| Japan | 6 |
| Australia | 5 |
| Belgium | 5 |
| Canada | 5 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| HOSP PLATO | 4 |
| JOHNSON & JOHNSON | 4 |
| MAHMOOD CLIN PHARMACOL CONSULTANCY LLC | 4 |
| US FOOD & DRUG ADMINISTRATION (FDA) | 4 |
| FUNDACIO HOSP ST BERNABE | 3 |
| GLAXOSMITHKLINE | 3 |
| HOSP GEN HOSP | 3 |
| HOSP RESIDENCIA ST CAMIL | 3 |
| HOSP UNIV SAGRAT COR | 3 |
| HOSPITAL COMARCAL INCA | 3 |
文章引用情况
1
S-1 in Patients with Advanced Esophagogastric Adenocarcinoma: Results from the Safety Compliance Observatory on Oral fluoroPyrimidines (SCOOP) Study2
Pharmacokinetics of the Oral Selective CXCR2 Antagonist AZD5069: A Summary of Eight Phase I Studies in Healthy Volunteers3
Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?4
Post Hoc Analysis of the CONFIDENCE II, PROTECT I, SHAKE THE HABIT I and SHAKE THE HABIT II Observational Studies in Mild to Moderate Hypertensive Patients Treated with Perindopril and Atorvastatin Concomitantly5
Assessment of Taste and Grittiness of Riomet((R)) ER Strawberry, Riomet((R)) ER Grape, Riomet((R)) Cherry, and Metformin Immediate-Release Tablets in Healthy Subjects6
Sealing Effects on the Storage Stability of the Cyanide Antidotal Candidate, Dimethyl Trisulfide7
Characterization of the Pharmacokinetics of Samidorphan in Healthy Volunteers: Absolute Bioavailability and the Effect of Food and Age8
Pharmacokinetics of Sublingual Buprenorphine Tablets Following Single and Multiple Doses in Chinese Participants With and Without Opioid Use Disorder9
Prediction of Drug-Drug Interactions Between Opioids and Overdosed Benzodiazepines Using Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation10
Impact of Primary Tumour Location and Early Tumour Shrinkage on Outcomes in Patients with RAS Wild-Type Metastatic Colorectal Cancer Following First-Line FOLFIRI Plus Panitumumab